search icon

      Market Snapshot

      blog search icon

      AVTE Stocks Valuation and Technical Analysis

      Aerovate Therapeutics, Inc.



      -1.75 (-9.95%)

      At Close: 4:00 PM

      AVTE Stock Performance Chart (1 Year)

      Aerovate Therapeutics, Inc.

      The price of a stock is the truest depiction of a company's value and what the market anticipates about its performance. A stock's market value is critical, but the process is plagued with uncertainty, leading to investor skepticism.

      However, in today's economic environment, investors may learn a lot about the market expectations of their target stocks by looking at stock's performance and important indicators.

      Comparing their expectations to the market could help investors estimate their prospective return.



      • 1 Week
      • 1 Month
      • Quarter
      • Half Year
      • 1 Year
      • YTD


      • N/A
      • N/A
      • N/A
      • N/A
      • N/A
      • N/A


      • N/A
      • N/A
      • N/A
      • N/A
      • N/A
      • N/A


      • -10.63%
      • 7.49%
      • -20.37%
      • 0.77%
      • 49.27%
      • -33.41%

      AVTE Fundamental Analysis

      • ATR1.75
      • Enterprise Value310.48M
      • Avg Vol (3 Months)72.79K
      • Avg Vol (10 Days)49.54K

      AVTE Stock Performance Chart (52 Weeks)

      • 52-Week High30.79
      • 52-Week Low11.13
      • 52-Week ChgN/A
      • S&P 500 52-Week ChgN/A

      AVTE Industry Analysis and Valuation


      • P/E (TTM)info icon
      • P/C (MRQ)info icon
      • P/S (TTM)info icon
      • P/B (MRQ)info icon


      • N/A
      • 3.99
      • N/A
      • 4.09

      Industry Avg

        Sector Median

          S&P 500

            AVTE Technical Analysis

            • SMA 20-4.41%
            • SMA 50-4.43%
            • SMA 200-8.42%
            • RSI (14)43.63

            Frequently Asked Questions


            How is AVTE price-to-earnings ratio currently?

            AVTE has a current P/E ratio of N/A.


            How are AVTE's price-to-sale and price-to-book ratios?

            The AVTE stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 4.09.


            Is Aerovate Therapeutics, Inc.'s price-to-cash ratio high or low?

            AVTE's price-to-cash (P/C) ratio is 3.99, an indicator that is currently being trending upward.


            What's current simple moving average (SMA) for AVTE?

            Based on AVTE's recent bid, its distance from 20 days simple moving average is -4.41%. It is -4.43% apart from 50 days simple moving average, and it is -8.42% apart from 200 days simple moving average.


            What is the 52-week price range for AVTE?

            The 52-week high for AVTE is $30.79 which is 0.32% away from the current price level whereas the distance of that from the 52-week low of $11.13 stands at 0.99%.


            An overview of AVTE's stock performance: how did it fare?

            The performance of AVTE stock was not encouraging with most of its significant price indictors in red. Aerovate Therapeutics, Inc. (NASDAQ: AVTE) shares have moved downward -9.95% or -$1.75 in the latest trading session and have loss -33.41% year-to-date (YTD). The stock has gained nearly 49.27% over the past year. After moving -20.37% over the trailing 3-month period, the stock is 0.77% higher in the 6-month period. Looking at its performance over the shorter term, it's down -10.63% a week and 7.49% a month.


            What is AVTE's 14-day relative strength index (RSI)?

            The current 14-day RSI for AVTE stock is 43.63. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.


            For AVTE, what is the average true range (ATR) for the past two weeks?

            ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Aerovate Therapeutics, Inc. (AVTE) has a 14-day ATR of 1.75.


            What is AVTE's current enterprise value?

            After closing at $15.84 with 24.61 Million of its shares outstanding, the current enterprise value of AVTE is roughly 310.48 Million.


            Over the past year, how has the stock price of AVTE changed?

            Aerovate Therapeutics, Inc. (NASDAQ: AVTE) is up N/A when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of N/A. AVTE stock price is also down -33.41% on its value in year-to-date trading.


            What is the average trading volume for AVTE shares?

            The number outstanding shares of AVTE is 24.61 Million, and of these 24.6 Million shares are freely available for trading. On average, AVTE stock has traded 49.54 Thousands shares per day for the past 10 days. A total of 97 Thousands shares changed hands during the last trading session with the average session volume of 72.79 Thousands shares.